We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $167B
1-Year Est. Return 44.17%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
+2.38%
1 Year Est. Return
+44.17%
3 Year Est. Return
+189.18%
5 Year Est. Return
+274.73%
10 Year Est. Return
+1,810.99%
AUM
$91.1B
AUM Growth
-$4.13B
Cap. Flow
-$5.05B
Cap. Flow %
-5.54%
Top 10 Hldgs %
23.1%
Holding
691
New
83
Increased
205
Reduced
333
Closed
61

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$677M
2
AGN
Allergan plc
AGN
+$437M
3
QCOM icon
Qualcomm
QCOM
+$387M
4
LULU icon
lululemon athletica
LULU
+$366M
5
NVDA icon
NVIDIA
NVDA
+$330M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.26%
2 Healthcare 16.99%
3 Technology 15.48%
4 Communication Services 12.63%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTCH icon
651
Match Group
MTCH
$9.54B
-991,089
Closed -$11M
ORCL icon
652
Oracle
ORCL
$435B
-44,417
Closed -$1.82M
PCRX icon
653
Pacira BioSciences
PCRX
$1.03B
-954,110
Closed -$50.5M
POST icon
654
Post Holdings
POST
$3.87B
-8,777
Closed -$395K
QLYS icon
655
Qualys
QLYS
$6.47B
-138,894
Closed -$3.52M
REGN icon
656
PUT
Regeneron Pharmaceuticals
REGN
$81.8B
-18,600
Closed -$6.7M
RH icon
657
RH
RH
$2.83B
-21,305
Closed -$893K
SCYX icon
658
SCYNEXIS
SCYX
$53.6M
-4,010
Closed -$1.29M
SHOO icon
659
Steven Madden
SHOO
$3.24B
-13,445
Closed -$332K
WBA
660
DELISTED
Walgreens Boots Alliance
WBA
-17,826
Closed -$1.5M
WELL icon
661
Welltower
WELL
$172B
-21,510
Closed -$1.49M
WVE icon
662
Wave Life Sciences
WVE
$993M
-370,825
Closed -$5.12M
XRX icon
663
Xerox
XRX
$402M
-2,753,066
Closed -$81M
TVRD
664
Tvardi Therapeutics
TVRD
$24.3M
-18,353
Closed -$4.11M
MRTX
665
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-65,789
Closed -$1.41M
KDNY
666
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-176,346
Closed -$11.3M
ACOR
667
DELISTED
Acorda Therapeutics
ACOR
-2,018
Closed -$6.4M
ENDP
668
DELISTED
Endo International plc
ENDP
-3,549,593
Closed -$99.9M
XLNX
669
DELISTED
Xilinx Inc
XLNX
-729,998
Closed -$34.6M
ALXN
670
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
-57,500
Closed -$8.01M
TIF
671
DELISTED
Tiffany & Co.
TIF
-2,642,089
Closed -$194M
WMGI
672
DELISTED
Wright Medical Group Inc
WMGI
-15,498
Closed -$257K
FCSC
673
DELISTED
Fibrocell Science Inc.
FCSC
-127,512
Closed -$4.78M
IMPV
674
DELISTED
Imperva, Inc.
IMPV
-8,913
Closed -$450K
RATE
675
DELISTED
Bankrate Inc
RATE
-30,793
Closed -$282K

Similar funds

Jennison Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jennison Associates withdrew a net $5.05B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.

  • Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
  • Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
  • Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
  • Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
  • Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
  • Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
  • Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.

Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.